https://orcid.org/0000-0002-3279-0196
References
- Bianchi FP, Germinario CA, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Tafuri S, Stefanizzi P; Control Room Working Group. Bnt162b2 mRNA COVID-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report. J Infect Dis. 2021;224(3):1–3. doi:10.1093/infdis/jiab262.
- Tré-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Della Vecchia A, Horeanga A, Papleux E, Vekemans M, Beukinga I, Blairon L. Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. J Infect. 2021;83(5):559–564. doi:10.1016/j.jinf.2021.08.031.
- European Center for Disease Control and Prevention. Interim public health considerations for the provision of additional COVID-19 vaccine doses. [accessed 2021 Jan 19]. https://www.ecdc.europa.eu/sites/default/files/documents/Interim-public-health-considerations-for-the-provision-of-additional-COVID-19-vaccine-doses.pdf.
- Italian Ministry of Health. Note n. 44591, 2021, 2 October. Timing between COVID vaccine and other vaccines. [accessed 2021 Jan 19]. http://www.quotidianosanita.it/allegati/allegato3558124.pdf.
- Center for Disease Control. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. [accessed 2021 Jan 18]. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html.
- Vimercati L, Bianchi FP, Mansi F, Ranieri B, Stefanizzi P, De Nitto S, Tafuri S. Influenza vaccination in health-care workers: an evaluation of an on-site vaccination strategy to increase vaccination uptake in HCWs of a South Italy Hospital. Hum Vaccin Immunother. 2019;15(12):2927–2932. doi:10.1080/21645515.2019.1625645.
- Bertoni L, Roncadori A, Gentili N, Danesi V, Massa I, Nanni O, Altini M, Gabutti G, Montella MT. How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers? Hum Vaccine Immunother. 2021;6:1–6.
- Tafuri S, Martinelli D, Caputi G, Balducci MT, Germinario C, Prato R. Simultaneous administration of vaccines in immunization protocols: an audit in healthcare workers in the Puglia region of Italy. Hum Vaccine. 2009;5(11):745–747. doi:10.4161/hv.5.11.9438.
- Stefanizzi P, Martinelli A, Bianchi FP, Migliore G, Tafuri S. Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs. Hum Vaccin Immunother. 2021;10:1–2.
- Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 Nov 17;10(2):167–179: S2213-2600(21)00409-4.
- Izikson R, Brune D, Bolduc JS, Bourron P, Fournier M, Moore TM, Pandey A, Perez L, Sater N, Shrestha A, et al. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Lancet Respir Med. 2022;10(4):392–402. doi:10.1016/S2213-2600(21)00557-9.
- Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdox1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFlucov): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277–2287. doi:10.1016/S0140-6736(21)02329-1.
- Domnich A, Orsi A, Trombetta CS, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals (Basel). 2022;15(3):322. doi:10.3390/ph15030322.